Possess state-of-the-Art manufacturing facilities for finished Dosage Forms & API's conforming to the most Stringent International Norms WHO-GMP, TGA (Australia), MHRA (UK). Manufacturing capacity (Finished Dosage) : 2300 million Tablets 64 million Ampoules 27 million Vials 84 million Capsules 18 million Dermatological products 62 million Oral liquid bottles Manufacturing capacity (API) : 1,50,0000 (15 lakhs) sq.
Our Cardia Division has worked towards the aim of providing the best quality products for patients suffering from cardiovascular diseases and Diabetes. We provide market leading Anti-Hyperlipidemics, Anti-Hypertensive & Anti-Diabetic products. Our range is appreciated for its effectiveness, long shelf life, and exact compositions catering to the ever increasing demand.